With thanks to our Sponsors
Xstrahl is a pioneer in the development of pre-clinical X–ray research solutions designed to deliver radiation doses to in vivo and in vitro biological specimens. Xstrahl’s advanced research systems include the SARRP (Small Animal Radiation Research Platform), the most advanced commercially available 3D image-guided micro irradiator. Headquartered in the UK with manufacturing facilities both in the UK and USA, Xstrahl operates globally through its international network of distributors.
Bio coming soon…
Bio coming soon…
Varian, of Palo Alto, California, is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian employs over 7,000 people, located at manufacturing sites, sales and support offices worldwide (www.varian.com).
Partnerships and collaborations drive medical innovation today. Our approach to open innovation helps us collaborate with like-minded scientists to work at the interface of scientific disciplines where true creativity and innovation occurs.
We have major research centres in Sweden and the US. We are head-quartered in Cambridge, where our scientists in antibody engineering and -technology, genomics and screening sciences are already working side by side with scientists from the Medical Research Council and Cancer Research UK.
Founded in 1986, MetaSystems designs and manufactures innovative solutions for automated, microscopy-based imaging since over thirty years. Based on the Metafer slide scanning platform, MetaSystems offers an unrivaled portfolio of imaging automation applications for radiation biodosimetry and mutation research. Metafer is the perfect tool for dose-response analyses – extremely fast to generate instant results in biodosimetry, compliant to GLP regulations, sensitive to detect even low dose effects in mutagenicity tests, and highly flexible.
Taylor & Francis is a leading publisher of scholarly journals, books, eBooks, text books and reference works in all areas of the Humanities, Social Sciences, Behavioural Sciences, Science, Technology and Medicine sectors. We publish Medicine & Health journal articles under the imprints Taylor & Francis, Cogent OA, and Dove Medical Press. We are proud to present the Kaplan Award at this year’s ICRR Conference.
If your work involves the culture of cells and you need strict, accurate control over O2, CO2, temperature and humidity, visit the Don Whitley Scientific stand. The Hypoxystation range of workstations has been developed specifically for cancer researchers and provides a range of features to help replicate the tumour microenvironment.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 38,000 e-book titles and many iconic reference works, including Gray’s Anatomy. Elsevier is part of RELX Group.
Originally developed by Augmenix, SpaceOAR™ Hydrogel is now part of the Boston Scientific portfolio. SpaceOAR® hydrogel, the company’s lead product, is a soft, absorbable gel spacer that pushes the rectum away from the prostate in men undergoing prostate radiotherapy, reducing rectal dose and injury to the rectum and surrounding tissues. To date, over 30,000 patients worldwide have benefitted from the SpaceOAR hydrogel procedure. More information be found at http://www.spaceoar.co.uk
The world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.
Bio coming soon…
Alpha Tau Medical focuses on R&D and commercialization of the first alpha-radiation-based cancer treatment for solid tumors, the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).
Alpha DaRT has several important advantages:
- Highly potent and conformal
- Low local toxicity, no negative systemic effects
- Enhances anti-tumor immune response
- Effective regardless of tumor oxygen level
- Short half-life – quick clinical outcome
- Disposable applicators – does not require capital equipment or special shielding
Envigo provides mission-critical products and research services for pharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. Our company is founded on the principle that research partnerships depend on unmatched expertise, unwavering dedication to customer service and shared goals, Envigo is committed to helping customers realize the full potential of their products and research which contribute to enhancing the lives of people and animals as well as protecting the environment.
Baker Ruskinn supplies Physoxia and Hypoxia based solutions for an ever-changing cell culture market. Recently Baker Ruskinn has introduced additional revolutionary non-workstation solutions, giving you greater choice and flexibility with which to achieve physiological cell culture. Visit us at stand 10 to learn more about our product range and trial one of the latest innovations, OxyGenie!
Helsinn Integrative Care is the line of high-quality medical devices and food supplements of the pharmaceutical company Helsinn Healthcare SA. Helsinn Integrative Care products are developed with premium ingredients selected and tested for high quality, manufactured by qualified facilities, and evaluated through clinical trials, to support a healthy life. Our products are commercialized worldwide either directly or through a selected network of commercial partners.
The History Committee of the Radiation Research Society presents a pictorial retrospective of the prior International Congresses of Radiation Research. The history of radiation research will be traced through the activities and attendees at these quadrennial international meetings, from the inaugural Congress in Burlington, VT, USA in 1958, to the most recent 15th Congress in Kyoto, Japan in 2015.
The LH Gray Memorial Trust was set up in 1967 to honour the memory of Hal Gray, a distinguished British scientist who made important contributions to the application of radiation physics to biology and medicine. The Trust was created jointly by The British Institute of Radiology, The Association for Radiation Research, and The Hospital Physicists Association. The Trust deed lays down that the principal purpose is: “the furthering for the benefit of the public the knowledge and understanding of all aspects and all applications of radiation and kindred sciences and to this end … promoting research in and the exchange of knowledge concerning such sciences by the organisation of conferences lectures and / or discussions.
Poster Prize Sponsor
The EACR is a global community of cancer researchers with more than 10,000 members in 100+ countries. We provide a wide variety of services to our community of members, organise scientific conferences of the highest quality, and facilitate communication and collaboration within the cancer research community. We also set out to raise the profile of cancer research in Europe and to make the case for sustained political and economic support.
Cancer Research UK is the largest independent funder of cancer research in Europe and the world’s leading charity dedicated to cancer research. We pioneer research to bring forward the day when all cancers are cured. Our ambition is to accelerate progress so that we see three quarters of people survive cancer within 20 years.
Lovelace Biomedical is a contract research organization with over 60 years of experience in radiation dosimetry, biomarkers and animal model development. Our facility was founded by the Atomic Energy Commission, later the Department of Energy, to improve our understanding of human health response to external radiation and radionuclides. Today we have built on that legacy to expand our capabilities in animal models, pharmacology and drug development.